CG Oncology Inc
NASDAQ:CGON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CG Oncology Inc
NASDAQ:CGON
|
US |
|
AJ Lucas Group Ltd
ASX:AJL
|
AU |
|
C
|
ConvaTec Group PLC
SWB:2CV
|
UK |
|
Fraser and Neave Ltd
SGX:F99
|
SG |
|
E
|
Emerson Electric Co
BMV:EMR
|
US |
|
A
|
Australian Critical Minerals Ltd
ASX:ACM
|
AU |
|
IRIS Business Services Ltd
NSE:IRIS
|
IN |
|
Mighty Kingdom Ltd
F:9UQ
|
AU |
|
Kaspien Holdings Inc
F:TWDA
|
US |
|
C3 Metals Inc
XTSX:CCCM
|
CA |
|
Comstock Holding Companies Inc
NASDAQ:CHCI
|
US |
|
Kopore Metals Ltd
ASX:KMT
|
AU |
|
Excite Technology Services Ltd
ASX:EXT
|
AU |
|
Shuangdeng Group Co Ltd
HKEX:6960
|
CN |
|
K
|
K&K Superstore Southern PCL
SET:KK
|
TH |
|
Karora Resources Inc
TSX:KRR
|
CA |
|
Construction Partners Inc
NASDAQ:ROAD
|
US |
|
Woodward Inc
NASDAQ:WWD
|
US |
|
Fu Yu Corporation Ltd
SGX:F13
|
SG |
Bankruptcy Probability
CG Oncology Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CG Oncology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
C
|
CG Oncology Inc
NASDAQ:CGON
|
5.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CG Oncology Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CG Oncology Inc has total debt of 3m USD. This includes both short-term (0 USD) and long-term (3m USD) debt.
You can find a full breakdown on its Balance Sheet.
